Natural Biocon (India)

Natural Biocon (India) Equity

The The Equity of Natural Biocon (India) (543207.BO) as of Oct 12, 2026 is 318.70 M INR. In the previous year, The Equity was 123.83 M INR — a change of 157.37% (higher).

Equity

318.70 MINR

YoY

157.37%

Last updated:

In 2025, Natural Biocon (India)'s equity was 318.70 M INR, a 157.37% increase from the 123.83 M INR equity in the previous year.

The Natural Biocon (India) Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
120.10 M INR
Jan 1, 2019
120.10 M INR
Jan 1, 2020
119.80 M INR
Jan 1, 2021
119.90 M INR
Jan 1, 2022
120.50 M INR
Jan 1, 2023
122.30 M INR
Jan 1, 2024
123.83 M INR
Jan 1, 2025
318.70 M INR
The Natural Biocon (India) Equity history
YEAREquityYoY
318.70 MINR+157.37%
123.83 MINR+1.25%
122.30 MINR+1.50%
120.50 MINR+0.50%
119.90 MINR+0.08%
119.80 MINR-0.25%
120.10 MINR0.00%
120.10 MINR+5.54%
113.80 MINR+0.09%
113.70 MINR0.00%
113.70 MINR—
Access this data via the Eulerpool API
Get Free API Key

Natural Biocon (India) Stock analysis

What does Natural Biocon (India) do? Natural Biocon (India) is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Natural Biocon (India)'s Equity

Natural Biocon (India)'s equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Natural Biocon (India)'s equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Natural Biocon (India)'s equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Natural Biocon (India)'s equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Natural Biocon (India)’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Natural Biocon (India) stock

The Equity of Natural Biocon (India) is 318.70 M INR in 2025.

The Equity of Natural Biocon (India) changed from 123.83 M INR to 318.70 M INR, representing a 157.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Natural Biocon (India) since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Natural Biocon (India) historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Natural Biocon (India)

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Natural Biocon (India)